BIO-B
Bio-Rad Laboratories, Inc.
NYSE · Healthcare · Medical - Devices · US
$381.37
+4.46%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+20.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Nov 10, 2025 | BARRY JAMES · officer: EVP, President, LSG | Sale | 700 | $306 |
| Oct 28, 2025 | DiVincenzo Jonathan P. · officer: President & COO | M-Exempt | 1,869 | $0.00 |
| Oct 28, 2025 | DiVincenzo Jonathan P. · officer: President & COO | F-InKind | 950 | $340 |
| Oct 21, 2025 | EVRAN SEDAT · officer: EVP, Global Supply Chain | F-InKind | 335 | $322 |
| Oct 21, 2025 | EVRAN SEDAT · officer: EVP, Global Supply Chain | M-Exempt | 1,044 | $0.00 |
| Sep 3, 2025 | BARRY JAMES · officer: EVP, President, LSG | M-Exempt | 602 | $0.00 |
| Sep 3, 2025 | COREY COLLEEN · officer: EVP, Global Human Resources | F-InKind | 398 | $298 |
| Sep 3, 2025 | Allison Schwartz · director | M-Exempt | 74 | $0.00 |
| Sep 3, 2025 | Allison Schwartz · director | M-Exempt | 147 | $0.00 |
| Sep 3, 2025 | SCHWARTZ NORMAN D · director, 10 percent owner, officer: Chairman & CEO | M-Exempt | 3,005 | $0.00 |
| Sep 3, 2025 | SCHWARTZ NORMAN D · director, 10 percent owner, officer: Chairman & CEO | M-Exempt | 2,082 | $0.00 |
| Sep 3, 2025 | BARRY JAMES · officer: EVP, President, LSG | F-InKind | 217 | $298 |
| Sep 3, 2025 | BARRY JAMES · officer: EVP, President, LSG | M-Exempt | 250 | $0.00 |
| Sep 3, 2025 | SCHWARTZ NORMAN D · director, 10 percent owner, officer: Chairman & CEO | F-InKind | 3,084 | $298 |
| Sep 3, 2025 | Allison Schwartz · director | M-Exempt | 31 | $0.00 |
| Sep 3, 2025 | COREY COLLEEN · officer: EVP, Global Human Resources | M-Exempt | 347 | $0.00 |
| Sep 3, 2025 | Allison Schwartz · director | M-Exempt | 42 | $0.00 |
| Sep 3, 2025 | COREY COLLEEN · officer: EVP, Global Human Resources | M-Exempt | 501 | $0.00 |
| Sep 3, 2025 | Allison Schwartz · director | F-InKind | 55 | $298 |
| Sep 3, 2025 | BARRY JAMES · officer: EVP, President, LSG | M-Exempt | 178 | $0.00 |
| Sep 3, 2025 | COREY COLLEEN · officer: EVP, Global Human Resources | M-Exempt | 1,102 | $0.00 |
| Sep 3, 2025 | SCHWARTZ NORMAN D · director, 10 percent owner, officer: Chairman & CEO | M-Exempt | 6,353 | $0.00 |
| Sep 3, 2025 | COREY COLLEEN · officer: EVP, Global Human Resources | M-Exempt | 254 | $0.00 |
| Sep 3, 2025 | BARRY JAMES · officer: EVP, President, LSG | M-Exempt | 174 | $0.00 |
| Sep 3, 2025 | SCHWARTZ NORMAN D · director, 10 percent owner, officer: Chairman & CEO | M-Exempt | 1,266 | $0.00 |
| Jul 29, 2025 | ENGELHARDT EVA ANETTE · officer: EVP, President, CDG | M-Exempt | 245 | $0.00 |
| Jul 29, 2025 | ENGELHARDT EVA ANETTE · officer: EVP, President, CDG | F-InKind | 88 | $264 |
| Apr 25, 2025 | ENLOE COURTNEY C · officer: EVP, General Counsel & Sec | F-InKind | 67 | $250 |
| Apr 25, 2025 | ENLOE COURTNEY C · officer: EVP, General Counsel & Sec | M-Exempt | 186 | $0.00 |
| Apr 25, 2025 | Lakkaraju Roop Kalyan · officer: EVP, Chief Financial Officer | F-InKind | 386 | $250 |
Institutional positioning
13F filings over the trailing two quarters
New 1Increased 1Reduced 2Sold out 7
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FLOW TRADERS U.S. LLC | New Position | 985 | May 15, 2026 |
| CSS LLC/IL | Reduced | 977 | May 15, 2026 |
| COLONY GROUP, LLC | Unchanged | 760 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 712 | May 15, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 170 | Jul 8, 2026 |
| WHITTIER TRUST CO | Unchanged | 160 | Apr 28, 2026 |
| UBS GROUP AG | Increased | 13 | May 5, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 15, 2026 |
| Focus Partners Wealth | Sold Out | 0 | May 15, 2026 |
| CSS LLC/IL | Sold Out | 0 | May 15, 2026 |
| WHITTIER TRUST CO | Sold Out | 0 | Apr 28, 2026 |
| FLOW TRADERS U.S. LLC | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| WELLS FARGO & COMPANY/MN | Sold Out | 0 | Jul 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Nov 10, 2025